---
title: "ST YATAI: Judicial enforcement reduced holdings by 70,400 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259316200.md"
description: "ST YATAI announced that on September 29, 2025, 70,400 shares of the listed company held by Lanzhou Yatai Mining Group Co., Ltd. were subject to judicial enforcement, accounting for 0.02% of the total share capital of the listed company. Before this change in equity, Yatai Mining held 28,977,300 shares of the listed company, accounting for 8.96% of the total share capital of the listed company; after the change, it held 28,906,900 shares, accounting for 8.94% of the total share capital of the listed company"
datetime: "2025-09-29T11:06:20.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259316200.md)
  - [en](https://longbridge.com/en/news/259316200.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259316200.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/259316200.md) | [繁體中文](https://longbridge.com/zh-HK/news/259316200.md)


# ST YATAI: Judicial enforcement reduced holdings by 70,400 shares

\*ST YATAI announced that on September 29, 2025, 70,400 shares of the listed company held by Lanzhou Yatai Mining Group Co., Ltd. were subject to judicial enforcement, accounting for 0.02% of the total share capital of the listed company. Before this change in equity, Yatai Mining held 28,977,300 shares of the listed company, accounting for 8.96% of the total share capital of the listed company; after the change, it held 28,906,900 shares, accounting for 8.94% of the total share capital of the listed company

### Related Stocks

- [YATAI (000691.CN)](https://longbridge.com/en/quote/000691.CN.md)

## Related News & Research

- [Tennis-Djokovic reaches Indian Wells last 16 as Pegula fights back to progress](https://longbridge.com/en/news/278446416.md)
- [ZAWYA-PRESSR: 740 Field visits as part of ADRA efforts to enhance market stability and ensure consumer protection](https://longbridge.com/en/news/278699660.md)
- [Junshi Biosciences’ Subcutaneous Toripalimab NDAs Accepted in China](https://longbridge.com/en/news/278445287.md)
- [Kainova reports positive top line results from Phase I EPRAD trial](https://longbridge.com/en/news/278702903.md)
- [13:46 ETNanchang Optoelectronic Industry Cluster brilla en ISLE 2026](https://longbridge.com/en/news/278597263.md)